Activation
of photoreceptor and olfactory cyclic nucleotidegated (CNG) channels involves distinct ligand-binding and channel-gating reactions. To dissociate binding from gating, we identified the first competitive antagonists of CNG channels: specific phosphorothioate derivatives of CAMP and cGMP. We also identified membrane-permeant forms of these molecules that are antagonists and that will be useful for elucidating physiological roles for CNG channels in intact cells. The photoreceptor and olfactory CNG channels determine which of the phosphorothioate derivatives are agonists and which are antagonists based on different structural features of the ligand. The photoreceptor channel uses the nature of the purine ring (adenine vs guanine), whereas the olfactory channel uses the isomeric position of the thiophosphate S atom (Rp vs Sp). Interestingly, the same ligand, Rp-cGMPS, has opposite effects on the two channels, activating the photoreceptor channel and antagonizing the olfactory channel. Because Rp-cGMPS binds to both channels but activates only one, the channels must differ in a protein region that couples binding to gating. Chimerit photoreceptor and olfactory CNG channels reveal that the cytoplasmic C-terminal domain determines whether bound ligand activates the channel successfully. Hence, the C terminus contains not only the cyclic nucleotide-binding site, but also a region that couples ligand binding to channel gating.
Key words: ligand-gated channels, CAMP, cGMP, photoreceptors, olfactory neurons, cyclic nucleotide-binding proteins Cyclic nucleotide-gated (CNG) channels are crucial components of the sensory transduction process in retinal photoreceptors and olfactory receptor neurons. During sensory stimulation, the opening or closing of these channels acts to transduce a change in the intracellular cyclic nucleotide concentration into an electrical signal. The CNG channels differ in that CAMP and cGMP are nearly equally effective in activating olfactory CNG channels (Nakamura and Gold, 1987; Dhallan et al., 1990; Goulding et al., 1992; Goulding et al., 1994) , whereas activation of photoreceptor CNG channels is highly selective for cGMP (Fesenko et al., 1985; Kaupp et al., 1989) . Recently, CNG channels have been found in a surprising assortment of other,cells (Yau et al., 1994) including retinal neurons (Nawy and Jahr, 1991; Ahmad et al., 1994) , cardiac myocytes (DiFrancesco et al., 1991; Biel et al., 1994) , and sperm (Weyand et al., 1994) . Membrane-permeant cyclic nucleotide analogs that are agonists have been useful for implicating the presence and identifying the functions of CNG channels in these cells. However, competitive antagonists of CNG channels have not yet been identified.
To identify antagonists of CNG channels, we examined molecules known to antagonize cyclic nucleotide-dependent protein kinases. The recent cloning of genes encoding the rod photoreceptor (Kaupp et al., 1989; Chen et al., 1993) and olfactory CNG channels (Dhallan et al., 1990; Goulding et al., 1992) has revealed a conserved region in the cytoplasmic C-terminal domain that is highly homologous to the cyclic nucleotide-binding domains of CAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase (PKG). Specific phosphorothioate derivatives of CAMP and cGMP inhibit the kinases competitively, with Rp-CAMPS inhibiting PKA (Botelho et al., 1988) and Rp-cGMPS inhibiting PKG (Butt et al., 1990) . Here, we show that these phosphorothioate derivatives also antagonize CNG channels. In addition, we show that derivatives of these molecules containing a p-chlorophenylthio (pCPT) group at the 8-position of the purine are higher-affinity antagonists with the advantage of being highly membrane-permeant.
Hence, these compounds may be useful tools for assessing physiological roles of CNG channels in various cells.
We have observed that some phosphorothioate derivatives have strikingly different effects on two classes of CNG channels. Thus, Rp-cGMPS is an agonist of photoreceptor CNG channels and an antagonist of olfactory CNG channels. We have used this observation to address the molecular mechanism of CNG channel activation. Activation of CNG channels is a multistep process involving distinct ligand-binding and channel-opening steps. Competitive antagonists bind without opening the channel and, therefore, dissociate these processes. Since the same ligand binds to both channels but selectively activates only one, the two CNG channel proteins must differ in a region that couples ligand binding to channel opening. To identify this region, we examined effects of the phosphorothioates on chimeric combinations between the two CNG channels. Our results show that the cytoplasmic C-terminal domain of CNG channels not only contains the cyclic nucleotide-binding site, but also contains a region that couples ligand binding to channel opening. (100 pM) was included in all perfusion solutions to block phosphodiesterase activity. CNG currents in excised patches from rods exposed to these solutions exhibited no spontaneous change in sensitivity to cyclic nucleotfdes for at least 30 min after excision (Gordon et al., 1992) . Recording from expressed CNG channels. Cloned bovine rod photoreceptor CNG channels (RET channels) (Kaupp et al., 1989) , cloned catfish olfactory receptor neuron CNG channels (OLF channels) (Goulding et al., 1992) , and chimeric (Goulding et al., 1994 ) CNG channels were used. The new RON-S2-BD chimera was constructed by substituting the OLF cyclic nucleotide-binding domain (amino acids 455L to 580E from chimera ROCB) (Goulding et al., 1994) into the corresponding position of RON-S2 (amino acids 485L to 610E) using restriction sites shared by the two sequences. Channels were expressed in Xenopus oocytes as described previously (Kramer and Siegelbaum, 1992 If Rp-CAMPS occupies the usual binding site without fully activating the channel, it should compete with more effective ligands, such as CAMP and cGMP. Figure 24 shows CNG current from native olfactory CNG channels elicited by CAMP and Rp-CAMPS and the two nucleotides in combination. Not only are the responses not additive, but Rp-CAMPS inhibits the current that would have been elicited by CAMP alone. The interaction between Rp-CAMPS and CAMP indeed is competitive, with Rp-CAMPS inhibiting CAMP-elicited current only at subsaturating CAMP concentrations, as shown in the doseresponse curves in Figure 2B . Thus, responses elicited by 2.5 or 10 P.M CAMP are inhibited, whereas responses to 50 PM CAMP are not. Rp-CAMPS also inhibits current elicited by cGMP competitively (data not shown).
Rp-CAMPS is an antagonist of the photoreceptor CNG channel
Rp-CAMPS appears to be a pure antagonist of CNG channels from outer segments of salamander rod photoreceptors. Rp-CAMPS, even at 2 mM, elicits no detectable CNG current in excised patches from rod outer segments (data not shown), but inhibits the response to subsaturating concentrations of cGMP competitively (e.g., lo-50 PM) by as much as 95% (Fig. 3A) . Rp-CAMPS has no effect on current elicited by maximal concentrations (1 mM) of cGMP (Fig. 3A) . Rp-CAMPS acts as a classic competitive antagonist; in six experiments using cloned photoreceptor channels expressed in oocytes, 500 FLM Rp-CAMPS shifted the mean K,,, for cGMP activation from 68.7 to 106 PM without IO pA J. Neurosci., February 15, 1996, 16( altering the shape of the dose-response relationship or the maximal response (Fig. 3B ).
Rp-8-pCPT CAMPS is a higher-affinity antagonist of photoreceptor CNG channels Photoreceptor CNG channels are activated by 8-thio-substituted analogs of cGMP and have a higher apparent affinity for these analogs than for cGMP itself (Brown et al., 1993) . Likewise, 8-pCPT-CAMP has a higher apparent affinity than CAMP for the olfactory CNG channel (our unpublished observations). These observations suggested that the pCPT form of Rp-CAMPS (Rp-8-pCPT-CAMPS) might be a higher-affinity antagonist for the photoreceptor CNG channel than Rp-CAMPS. Indeed, we find that Rp-8-pCPT-CAMPS activates no current when applied alone, but antagonizes activation of photoreceptor CNG channels strongly when applied together-with cGMP ( Fig. 44 ). Rp-CAMPS exhibits an IC,, of 435 FM, whereas Rp-8-pCPT-CAMPS exhibits an IC,, of 199 PM (Fig. 4B ).
Rp-CAMPS alters gating of CNG channels
Rp-CAMPS could inhibit the olfactory CNG current by reducing the number, single-channel conductance, and/or open probability of individual CNG channels. Figure 5A shows a recording from an oocyte patch containing only a single OLF CNG channel. Application of Rp-CAMPS increases the interval between bursts of channel openings and decreases the duration of these bursts, causing a decrease in open probability.
Rp-CAMPS does not alter the number of active channels in the 15, 1996, 16(4) elicited by 10 and 100 PM cGMP, but has no effect on the response elicited by a saturating concentration of cGMP (1000 FM). B, Dose-response curves of cGMP activation of the cloned RET channel expressed in oocytes in the absence (filled circles) and presence (open squares) of 500 pM Rp-CAMPS for six measurements each. Solid curves show Hill fits with K1,2, n, and I,,,, of 71 pM, 2.1, and 1.00 with CAMP alone and 106 PM, 2.2, and 1.00 in the presence of Rp-CAMPS, respectively.
patch, nor does it alter single-channel cpnductance (56.7 ? 2.1 pS before and 57.3 k 2.2 pS after adding Rp-CAMPS; n = 4). The amplitude of a subconductance state observed when single-channel events are recorded with high bandwidth also is unaltered by Rp-CAMPS (29.7 t 1.4 pS before and 29.7 -C 1.5 pS after Rp-CAMPS; n = 7). Kinetic analysis reveals that Rp-CAMPS greatly increases the time constant of the major component of the closed time distribution from 9.3 to 21.2 msec. Figure 5B shows that the open time distribution can be fit with three exponential components (T = 0.3, 6.5, and 38.4 msec). Differential effects of the Rp-phosphorothioate derivatives of cGMP on olfactory and photoreceptor CNG channels Sp-cGMPS, a phosphorothioate derivative of cGMP, is an agonist of olfactory CNG channels, activating 80% of the maximal CNG current when applied at 3 mM, without reducing the response to coapplied cGMP (data not shown). Previous studies also have shown that Sp-cGMPS is a full agonist of photoreceptor CNG channels (Zimmerman et al., 1985) . Whereas the Sp isomer appears to be a full agonist for olfactory and photoreceptor CNG channels, the Rp isomer affects the two channels in opposite ways: photoreceptor CNG channels are activated and olfactory CNG channels are inhibited competitively. These experiments used cloned CNG channels expressed in Xenopus oocytes: OLF channels derived from catfish olfactory neurons, and RET CNG channels derived from bovine rod photoreceptors. RET channels are activated by both Rp-cGMPS and Rp-SpCPT-cGMPS, and neither compound antagonizes activation of the channels elicited by 25 pM cGMP. In fact, Rp-cGMPS is a low-affinity agonist of RET channels, with 1 mM activating 35 +-6% (n = 3) of the maximal CNG current. This value is consistent with the findings of Zimmerman et al. (198.5) , who showed that Rp-cGMPS activates native rod CNG channels with a K,,, of -1200 pM. Much lower concentrations of Rp-8-pCPTcGMPS are required to activate the RET channels (e.g., 10 PM). However, at high concentrations (e.g., 100 PM), Rp-SpCPTcGMPS apparently causes open-channel block of the RET channel that obscures observation of full activation of the current. The blocking effect is voltage-dependent, suggesting that Rp-SpCPTcGMPS crosses part of the membrane electrical field and occludes the pore. At highly depolarized potentials (+120 mV), the block is largely relieved, and the maximal RET CNG current activated by Rp-SpCPT-cGMPS is estimated to be 93% of the maximal cGMP response, with an estimated K,,z of 11 FM (Fig. 6A) .
In contrast to RET channels, OLF channels exhibit little activation in response to 500 PM up-CGMPS (<2%; IZ = 3). Rp-8-pCPT-cGMPS is only slightly more effective, activating only 4-9% of the maximal CNG current (Fig. 6B ). Despite its low efficacy, Rp-SpCPT-cGMPS does bind to the OLF channel, since 500 PM strongly antagonizes cGMP activation of OLF channels (Fig. 6B) . The inhibition produced by Rp&pCPT-cGMPS is competitive; it blocks activation of CNG current elicited by 25-100 PM cGMP completely, and inhibits a progressively smaller percentage of the CNG current elicited by l-10 mM cGMP. The competitive nature of the inhibition caused by Rp-S-pCPT-cGMPS suggests that it binds to the same site as does cGMP and demonstrates that direct block of the channel is not a major contributor to inhibition of the OLF channel.
Molecular determinant of agonist versus antagonist action elicited by Rp-8-pCPT-cGMPS
The observation that Rp-SpCPT-cGMPS is an agonist for the RET channel and an antagonist for the OLF channel suggests that even though the two channels bind the ligand, they differ in a protein region that couples binding to channel gating. To identify this region, we examined chimeric combinations between RET and OLF channels constructed previously to identify regions un- derlying the different responses of RET and OLF channels to CAMP and cGMP (Goulding et al., 1994) . This previous study found that two domains account for the differences in channel activation by CAMP and cGMP: one domain consists of the N terminus and first two membrane-spanning segments (N-S2 domain); the second domain is the conserved cyclic nucleotidebinding region in the C terminus of the protein.
To test the role of the C terminus in determining the response to Rp-S-pCPT-cGMPS, we examined ROC, the RET channel with a substituted OLF C terminus, and ORC, the OLF channel with a substituted RET C terminus. Figure 7 shows the response of these chimeras to Rp-8-pCPT-cGMPS.
As noted above, Rp-8-pCPT-cGMPS activates RET and fails to antagonize the response elicited by cGMP, whereas with OLF, Rp-S-pCPT-cGMPS antagonizes cGMP activation competitively and elicits very little current on its own. ORC behaves similarly to RET; Rp-S-pCPTcGMPS activates the CNG current fully and fails to antagonize the cGMP response (Fig. 7A) . Likewise, ROC behaves like OLF; Rp-S-pCPT-cGMPS activates little current and strongly antagonizes activation by cGMP in an apparently competitive manner (Fig. 7B) . Hence, the C-terminal domain alone can account for the difference in the actions of Rp-S-pCPT-cGMPS on the RET and OLF channels.
Does the N-S2 domain also contribute to determining whether Rp-S-pCPT-cGMPS is an agonist or antagonist? To address this question, we examined RON-S2, a chimera consisting of the RET channel with a substituted OLF N-S2 domain (Fig. 7C) . Like RET, RON-S2 is activated fully by Rp-&pCPT-cGMPS, and no antagonism of cGMP action is evident. In fact, Rp-S-pCPTcGMPS activates RON-S2 with a lo-fold higher apparent affinity than it does for RET, and indeed Rp-cGMPS also can be observed to activate this channel fully. Hence, the N-S2 domain does not account for the differences in pharmacology of RET and OLF regarding Rp-S-pCPT-cGMPS and Rp-cGMPS. An additional chimeric channel enabled us to map the molecular determinant of Rp-cGMPS action to the conserved cyclic nucleotide-binding domain within the C-terminal domain. Recent studies have shown that gating of the bovine rod channel and the rat olfactory channel can be modulated when Nizf ions bind to specific histidine residues located in the cytoplasmic C terminus just beyond the last transmembrane domain, but outside of the putative cyclic nucleotide-binding site (Gordon and Zagotta, 1995a,b) . These studies suggest that this region plays an important role in regulating channel gating and may determine the efficacy of CNG channels to different cyclic nucleotides. To test whether this region, or the conserved cyclic nucleotide-binding domain, contains the determinant for Rp-S-pCPT-cGMPS action, we generated a new chimera that contains both the N-S2 domain and the conserved cyclic nucleotide-binding dom.ain of the OLF channel, but is otherwise identical to RET. This chimeric channel, RON-SZBD, demonstrates that the conserved cyclic nucleotide-binding domain indeed is the crucial site for determining Rp-8-pCPTcGMPS action. In contrast to where Rp-8-pCPTcGMPS is a full agonist, Rp-S-pCPT-cGMPS elicits remarkably little activation of CNG current in RON-SZBD channels (0.2% of the maximal current at 1 mM; n = 3). However, Rp-8-pCPTcGMPS does bind to RON-S2-BD channels. Figure 70 shows that Rp-8-pCPT-cGMPS fully antagonizes CNG current elicited by cGMP in these channels, exhibiting an IC,, of 51 pM. The inhibition was equally effective at +80 mV as at -80 mV, establishing that voltage-dependent block was not involved. Rp-cGMPS Rp-8-pCPT-cGMPS concentration (PM) Figure 7 . The molecular determinant for Rp-&pCPT-cGMPS action on CNG channels. A, Full activation of ORC channels by Rp-S-pCPT-cGMPS. Concentrations of Rp-8-pCPT-cGMPS up to 1 mM continued to activate CNG current fully (data not shown). Curve shows Hill fit with K,,,, n, and I,, of 0.10 p,M, 1.1, and 1.03, respectively (N = 3-6 patches). B, Antagonism of ROC channels by Rp-S-pCPT-cGMPS. Mean data from three experiments show the effect of cGMP alone (Open circles) and cGMP in the presence of 500 pM Rp-&pCPT-cGMPS ( p o en s 4 uares). Cures show Hill fits with K,,, = 115 and 8700 FM, respectively. Application of 1 mM Rp-S-pCPT-cGMPS alone activated 7.0 t 7.0% of the maxima1 CNG current (filled circles). C, Full activation of RON-S2 channels by Rp-B-pCPT-cGMPS. Cuwe shows Hill fit to the data with K,,,, n, and I,,, of 71 PM, 2.1, and 0.98, respectively (N = 4 patches). D, Antagonism of RON-S2-BD channels by Rp-8-pCPT-cGMPS. Inhibition of responses to half-saturating cGMP concentration (250 pM) by different concentrations of Rp-8-pCPT-cGMPS. The estimated IC,,) was 51 FM. Data represent mean -C SEM for three measurements. Application of 1 mM Rp-8-pCPT-cGMPS alone activated 0.2 t 0.1% of the maxima1 CNG current (N = 2 patches). mM) also antagonized cGMP-activated current by -30% while eliciting no activation of the channels.
DISCUSSION
Our results show that phosphorothioate derivatives of CAMP and cGMP have different actions on photoreceptor and olfactory CNG channels. Table 1 summarizes these effects on cloned versions of the channels (RET and OLF). The phosphorothioate ligand molecules differ both in their purine rings (adenine in cAh4P vs guanine in cGMP) and in the position of the sulfur atom on the cyclized phosphate (S, or axial position, vs R, or equatorial position). These two parts of the ligand apparently are recognized in different ways by the RET and OLF channels. With regard to gating, the OLF channel is indifferent to the nature of the purine ring, but instead discriminates between the Rp and Sp isomers, with the Rp isomers being antagonists and the Sp isomers being agonists. In contrast, the gating of RET channels does discriminate between purine rings, with cGMP analogs being agonists and CAMP analogs being antagonists. Thus, although the putative binding sites of the CNG channels share considerable sequence homology, they differ in the way that ligand binding is coupled to channel gating.
Table 1 also shows that Rp-cGMPS is an agonist for the RET channel and an antagonist for the OLF channel. Which parts of the proteins are responsible for this difference? Possible regions include all or part of the binding site on the C terminus, and the NS2 region, which has been implicated in mediating differences in the ability of CAMP and cGMP to activate the RET and OLF channels (Goulding et al., 1994) . The N-S2 domain does not appear to be responsible, because introduction of the OLF N-S2 region into RET does not transform the pharmacological properties of the channel, but instead makes Rp-cGMPS and its 8-pCPT derivative even more potent agonists. Rather, our experiments with the ROC and ORC chimeras show that the relevant part of the CNG channel protein for deter- Goulding et al. (1994) . 'CAMP activates 2% of the maximal RET CNG current (Goulding et al., 1994) . Saturating CAMP activates 25% of the native rod CNG current and antagonizes activation by cGMP (Furman and Tanaka, 1989) . 'Rp-CAMPS activates 2% of the maximal OLF CNG current and 34% of the native olfactory CNG current at saturation. '1 rn~ elicits no detectable response and reduces current elicited by 25 fin cGMP by 30%. fSaturating Rp-cGMPS and Rp-R-pCPT-cGMPS activate 2 and 5-9% of the maximal OLF CNG current, respectively. "3 rn~ Sp-cGMPS activates 80% of the maximal OLF CNG current, whereas antagonism of the cGMP response is not detected. "1 rn~ activates 32% of the maximal CNG current, and antagonism is not detected. In native rod CNG channels, k,,, = 210 PM (Zimmerman et al., 1985) .
mining ago&m versus antagonism is the C terminus. Comparison of RON-S2 and RON-S2-BD further narrows the localization of the crucial site to the 125-amino-acid putative cyclic nucleotide-binding domain. Hence, Rp-S-pCPT-cGMPS is a full agonist on RON-S2 and a nearly pure antagonist on RON-S%-BD. The 125-amino-acid region is still rather broadly defined. To pinpoint specific amino acid differences that account for the functional differences in phosphorothioate action, additional chimeras and point mutants will need to be constructed and tested.
The putative cyclic nucleotide-binding site shares sequence homology with catabolite-gene activator protein (CAP), a bacterial CAMP-binding protein (Altenhofen et al., 1991; Goulding et al., 1994) . X-ray crystallography of CAP has shown that its CAMPbinding domain is composed of three oc-helices (A, B, and C) and an eight-stranded P-barrel structure (Weber and Steitz, 1987; Shabb and Corbin, 1992) . The purine ring of CAMP contacts residues in the C a-helix, whereas the cyclized phosphate contacts residues in the P-barrel. Because the RET and OLF channels choose which ligand is an agonist or antagonist based on different parts of the cyclic nucleotide molecule, the part of the protein that discriminates between agonist and antagonist may differ between RET and OLF. The OLF channel discriminates between agonist and antagonist based on the phosphorothioate group; hence, the region that determines whether this channel will gate may be located in a region homologous to the p-barrel. Likewise, because the RET channel discriminates between agonist and antagonist based on the purine ring, a region homologous to the C a-helix also may be responsible in this channel. This hypothesis may be tested by generation of additional constructs.
The specific amino acids that determine whether Rp-cGMPS and its pCPT derivative are agonists or antagonists are likely to be different from those identified previously as crucial for binding the phosphate and for mediating activation in both CAP and in the cyclic nucleotide-dependent protein kinases. Rp-CAMPS strongly activates CAP, whereas Sp-CAMPS is a weak activator (Scholubbers et al., 1984) . Two amino acids, Args2 and Ser'a, are thought to interact with the phosphate and determine the chiral specificity of CAP activation (Weber and Steitz, 1987) . Amino acids in positions equivalent to Args2 and Set-s3 in PKA and PKG likewise are crucial for activation by CAMP and cGMP (Weber et al., 1989) and determine whether Rp-CAMPS acts as an agonist or an antagonist in PKA (Dostmann and Taylor, 1991) . These putative contact sites with cyclic nucleotides also are highly conserved in the CNG channels ("RTAN" sequence in the p7 domain) (Goulding et al., 1994) and the specific nature of the amino acids also is crucial for activation (Altenhofen et al., 1991) . However, because the sequences of RET and OLF are identical in this region, this cannot be the site responsible for functional differences between the two channels.
The chimeric substitutions that convert the Rp-cGMPS ligands from agonists to antagonists also cause a decrease in the apparent affinity for cGMP itself, suggesting that the coupling between binding and gating has been weakened generally in these channels. Is the shift from agonist to antagonist as the putative binding domain is converted from RET to OLF caused by a general change in the ability of ligands to activate the channel? Indeed, in a variety of CNG channel chimeras there is a correlated change in the ability of CAMP and cGMP to gate the channels, caused by similar shifts in the free energy changes when each of the cyclic nucleotides open the channel (Goulding et al., 1994; Gordon and Zagotta, 1995b) . However, simply decreasing the ease of activation cannot explain why Rp-S-pCPT-cGMPS is converted from an agonist to an antagonist in RON-S2 versus RON-S2-BD.
Rp-8-pCPT-cGMPS is a full agonist of higher affinity than cGMP for RON-S2 (K,,2 values are 1 and 4 FM, respectively; Fig. 7C ) (Goulding et al., 1994) . Therefore, decreasing the ability to open when the binding site is saturated would reduce the effectiveness of cGMP at least as much as it would Rp-S-pCPT-cGMPS.
However, the effect of Rp-S-pCPT-cGMPS is transformed selectively in RON-S2-BD.
In RON-S2-BD, the analog is almost completely ineffective at opening the channel. However, it still has a higher apparent affinity than cGMP for binding to the channel (IC,, of 51 PM, K,,, of 310 FM, respectively; Fig. 70 ) (our unpublished observations). Hence, the putative binding domain must contain regions that determines selectively whether these phosphorothioate derivatives are agonists or antagonists in addition to residues that determine the effectiveness of cGMP and CAMP.
In addition to their usefulness in probing the molecular basis of CNG channel activation, the phosphorothioate antagonists of CNG channels will be useful for investigating the functions of CNG channels in intact cells. These compounds will be useful for classifying CNG channels in other cell types as OLF-like or RETlike, or those having a novel pharmacological profile. A possible complicating factor is that recent studies show that CNG channels in photoreceptors (Chen et al., 1994) and olfactory receptor neurons (Bradley et al., 1994; Liman and Buck, 1994) are heteromeric, containing P-subunits in addition to the original a-subunits (e.g., RET and OLF). Although the native CNG channels differ from the cloned CNG channels in having higher sensitivities to CAMP and cGMP, our results show that qualitatively, the pharmacological profiles of the native channels are nearly identical to those of cloned RET and OLF channels.
Keeping in mind their effects on cyclic nucleotide-dependent protein kinases and PDEs, the phosphorothioate cyclic nucleotide derivatives thus can be added to the arsenal of agents used to implicate CNG channels in physio-logical responses. In particular, the membrane-permeant pCPT derivatives of Rp-CAMPS and Rp-cGMPS are effective antagonists of CNG channels and will compliment the use of agonists in identifying the role of CNG channels in intact cells.
